Image

A Registry for People With T-cell Lymphoma

Recruiting
Both
Phase N/A

T-cell lymphoma is a type of blood cancer that affects the T-cells, which are a part of your immune system. This study aims to collect information about people with T-cell lymphoma to help doctors find better treatments in the future. To be part of this study, you need to give written permission and have a tumor sample available. You must also have one of the specific types of T-cell lymphoma listed by doctors. This includes many types like mycosis fungoides and anaplastic large cell lymphoma. However, if you're not receiving treatment for certain types, you cannot join. The study won't interfere with other treatments or trials you might be a part of.

  • There are no direct treatments involved in this registry, just data collection.
  • Participation may require sharing medical history and tumor samples.
  • Can join even if participating in other medical studies or treatments.

Remember, participating in this study could help improve future treatments for T-cell lymphoma patients.

Study details
    T-cell Lymphoma
    NK-Cell Lymphoma
    T-cell Prolymphocytic Leukemia
    T-cell Large Granular Lymphocytic Leukemia
    Chronic Lymphoproliferative Disorder of NK Cells
    Aggressive NK-cell Leukemia
    Systemic Epstein-Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood (Disorder)
    Systemic Epstein Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood
    Chronic Active EBV Infection of T-and NK-Cell Type
    Systemic Form
    Hydroa Vacciniforme-Like Lymphoproliferative Disorder
    Adult T-cell Leukemia/Lymphoma
    Extranodal NK/T-cell Lymphoma
    Nasal Type
    Enteropathy-associated T-cell Lymphoma
    Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
    Intestinal T-Cell Lymphoma
    Not Otherwise Specified
    Indolent T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract
    Hepatosplenic T-cell Lymphoma
    Subcutaneous Panniculitis-Like T-Cell Lymphoma
    Mycosis Fungoides
    Sezary Syndrome
    Primary Cutaneous Anaplastic Large Cell Lymphoma
    Primary Cutaneous T-cell Lymphoma
    Primary Cutaneous CD8-Positive Aggressive Epidermotropic T-Cell Lymphoma
    Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma
    Peripheral T-Cell Lymphoma
    Not Otherwise Specified
    Angioimmunoblastic T-cell Lymphoma
    Follicular T-Cell Lymphoma
    Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
    Anaplastic Large Cell Lymphoma
    ALK-Positive
    Anaplastic Large Cell Lymphoma
    ALK-negative
    Breast Implant-Associated Anaplastic Large Cell Lymphoma

NCT05978141

Memorial Sloan Kettering Cancer Center

27 June 2024

Not finding the right Trial?

You can also call our Patient navigators who can help you to find the right trial.

Call now
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.